Patients with chronic lymphocytic leukemia with high-risk genomic features have inferior outcome on successive Cancer and Leukemia Group B trials with alemtuzumab consolidation: subgroup analysis from CALGB 19901 and CALGB 10101.
| Image |  |
|---|---|
| Description | scientific article published on 09 May 2013 |
| Author/s |
author: Guido Marcucci Kanti Rai Nyla A Heerema Bercedis Peterson Jeffrey A Jones Amy S Ruppert Thomas Lin Pedersen John C. Byrd Richard A. Larson Weiqiang Zhao |
| Publication date | May 9, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |